Journal of the Formosan Medical Association (May 2018)

Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan

  • Sheng-Nan Lu,
  • Jing-Houng Wang,
  • Chien-Wei Su,
  • Tsang-En Wang,
  • Chia-Yen Dai,
  • Chien-Hung Chen,
  • Ran-Chou Chen,
  • Sien-Sing Yang,
  • Chien-Fu Hung,
  • Shiu-Feng Huang,
  • Li-Ying Liao,
  • Jing-Houng Wang,
  • Sheng-Nan Lu,
  • Chien-Hung Chen,
  • The-Ia Huo,
  • Cheng-Chung Wu,
  • Po-Huang Lee,
  • Chin-Tsung Ting,
  • Wei-Chen Lee,
  • Gar-Yang Chau,
  • Chien-Fu Hung,
  • Chih-Chi Wang,
  • King-The Lee,
  • Jing-Houng Wang,
  • Yi-Hsiang Huang,
  • Chien-Wei Su,
  • Ming-Chih Ho,
  • Shi-Ming Lin,
  • Guan-Tarn Huang,
  • Kuan-Yang Chen,
  • Tsang-En Wang,
  • Xi-Zhang Lin,
  • Li-Ying Liao,
  • Jing-Houng Wang,
  • Jen-I. Hwang,
  • Gar-Yang Chau,
  • Yi-You Chiou,
  • Chung-Kwe Wang,
  • Jui-Ting Hu,
  • Sheng-Nan Lu,
  • Shinn-Cherng Chen,
  • Jen-I. Hwang,
  • Po-Chin Liang,
  • Chien-Fu Hung,
  • Rheun-Chuan Lee,
  • Ding-Kwo Wu,
  • Cheng-Yao Lin,
  • Chen-Chun Lin,
  • Ran-Chou Chen,
  • Ann-Lii Cheng,
  • Chiun Hsu,
  • Yi-Hsiang Huang,
  • Yee Chao,
  • Li-Tzong Chen,
  • Po-Ming Wang,
  • Po-Ming Wang,
  • Ji-Hong Hong,
  • Hsuan-Chih Hsu,
  • Shang-Wen Chen,
  • Stephen Wan Leung,
  • Jason Chia-Hsien Cheng,
  • Chen-Chun Lin,
  • Chien-Fu Hung,
  • Jaw-Ching Wu,
  • Chien-Wei Su,
  • Shi-Ming Lin,
  • Chun-Ying Wu,
  • Yao-Chun Hsu,
  • Chao-Wei Hsu,
  • Yen-Hsuan Ni,
  • Chien-Wei Su,
  • Chien-Hung Chen,
  • Cheng-Chung Wu,
  • Shi-Ming Lin,
  • Jen-I. Hwang,
  • Chiun Hsu,
  • Shang-Wen Chen,
  • Chih-Lin Lin

Journal volume & issue
Vol. 117, no. 5
pp. 381 – 403

Abstract

Read online

Background: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality in Taiwan. To help clinical physicians to manage patients with HCC, the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan produced the management consensus guideline for HCC. Methods: The recommendations focus on nine important issues on management of HCC, including surveillance, diagnosis, staging, surgery, local ablation, transarterial chemoembolization/transarterial radioembolization/hepatic arterial infusion chemotherapy, systemic therapy, radiotherapy, and prevention. Results: The consensus statements were discussed, debated and got consensus in each expert team. And then the statements were sent to all of the experts for further discussion and refinement. Finally, all of the experts were invited to vote for the statements, including the level of evidence and recommendation. Conclusion: With the development of the management consensus guideline, HCC patients could benefit from the optimal therapeutic modality. Keywords: Diagnosis, Hepatocellular carcinoma, Staging, Surveillance, Treatment